As also shown in this Special Issue of DMM, we recently demonstrated normalization of a skeletal myopathy using a MEK inhibitor in an adult CS Hras mouse model (Tidyman et al., 2021). The gene discussed is HRAS; the disease is skeletal muscle disorder.